Nevada Cancer Control Summit

2022 Agenda

Please note, this agenda is still in draft. Topic names are subject to change. Speakers are still being confirmed.

8 a.m. - Breakfast sponsored by Comprehensive Cancer Centers of Nevada

8:30 - 9:15 a.m. Cancer In Nevada: Where are we?
Dr. Lisa Richardson, MD, MPH, Director, CDC Division of Cancer Prevention and Control 
In this session we'll look at current cancer incidence and mortality in Nevada, disparities, barriers, impacts of COVID-19, current screening guidelines, and more.

9:15 - 10 a.m. Precision Oncology: Delivering Exact and Reliable Cancer Care
Dr. Lee Schwartzberg, Renown Institute for Cancer

10 - 10:30 a.m. Exhibits and Break, sponsored by Comprehensive Cancer Centers of Nevada

10:30 - 11:15 a.m. What's New in Treatment of Myeloma
Dr. Mehrdad Abedi, Professor, Hematology/Oncology, U.C. Davis Health System

11:15 a.m. - 12 p.m. Practice Improvement: Expanding the Support Team to Increase Capacity
Katherine M. Salkanovic, MBA-HM, CPXP, Cure 4 The Kids
In this session we'll look at how adding patient support staff can help to improve patient-provider communication, enhance patient compliance, reduce patient anxiety and stress, and free up time for high- and mid-level providers to treat patients. 

12 - 1:30 p.m. Lunch, Exhibits & Awards sponsored by GRAIL

1:30 - 2:45 p.m. Panel Discussion: Educating and Retaining a Cancer Careforce
We'll facilitate a discussion with leaders from Nevada's medical and nursing schools to learn what schools are doing to help fill the education and workforce pipeline and how Nevada's healthcare providers and stakeholders can help to retain newly trained workers. Panel participants include Luther Brewster, Roseman University; Brian Lauf, University of Nevada, Reno; Andrea Gregg, High Sierra AHEC; and Megan Comlossy, The Larsen Institute.

2:45 - 3 p.m. Exhibits and Break, sponsored by Comprehensive Cancer Centers of Nevada

3 - 3:45 p.m. Cell/Immune and Transplant Therapy for High Risk Acute Lymphoblastic Leukemia—Guiding Therapies with Next-Generation Sequence-MRD,
Dr.  Michael A. Pulsipher, Professor of Pediatrics; Division Chief, Pediatric Hematology and Oncology; Director, Children’s and Adolescent Cancer Initiative at Huntsman Cancer Institute and Intermountain Primary Children’s Hospital 

3:45 - 4:15 p.m. Nevada Lung Cancer Screening: How We Are Failing and How We Can Fix It, part 1
Dr. Chivonne Harrigal
This two-part session, offered in response to community demand, will look at the current state of lung cancer screening in Nevada, why lung cancer screening works, challenges to lung cancer screening, and access concerns.

4:15 - 5 p.m. Nevada Lung Cancer Screening: How We Are Failing and How We Can Fix It, part 2
Angela Criswell, MA, Associate Director of Quality Screening & Program Initiatives, GO2 Foundation For Lung Cancer
In part two of this session, we'll learn from a successful, evidence-based lung cancer screening program how to improve lung cancer screening rates and reduce mortality and morbidity from the disease, and discuss current collaborations and initiatives in Nevada that can move us forward in improving lung cancer screening in our state.

CME Accreditation & Designation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nevada, Reno School of Medicine and the Nevada Cancer Coalition. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education in physicians.

The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 6 hours AMA PRA Category 1 Credits ^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Continuing Education Credit

The University of Nevada, Reno School of Medicine approves this program for 6 hours of nursing continuing education credit.

The National Cancer Registrars Association Program Recognition Committee has determined “2022 Nevada Cancer Control Summit” program supports 6.25 CE hours of which 0 hours meet the Category A requirement.  

Social workers can submit paperwork to their accrediting board for credit.

 Las Vegas Venue TBD

2022 SPONSORSHIP & EXHIBIT OPPORTUNITIES - CLOSED

The 2023 Nevada Cancer Control Summit will be in Las Vegas.
If you'd like to be notified when exhibit opportunities open, please contact Kristen Hackbarth to be added to the list.

Closing Gaps in Cancer Prevention and Early Detection, Dr. Lisa Richardson, CDC, Sept. 13, 2022